Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Regional conduction velocities determined by noninvasive mapping are associated with arrhythmia-free survival after atrial fibrillation ablation

  • Invers-Rubio, Eric
  • Hernández-Romero, Ismael
  • Reventós-Presmanes, Jana
  • Ferró, Elisenda
  • Guichard, Jean Baptiste
  • Regany-Closa, Mariona
  • Pellicer-Sendra, Berta
  • Borrás, Roger
  • Tolosana, José María
  • Prat-Gonzalez, Susanna
  • Porta-Sanchez, Andreu
  • Arbelo, Elena
  • Guasch, Eduard
  • Sitges, Marta
  • Brugada, Josep
  • Roca-Luque, Ivo
  • Lluís Mont
  • TF Althoff
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
  • Andreu M. Climent|||0000-0002-7260-8811
[EN] BACKGROUND Atrial arrhythmogenic substrate is a key determinant of atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI), and reduced conduction velocities have been linked to adverse outcome. However, a noninvasive method to assess such electrophysiologic substrate is not available to date. OBJECTIVE This study aimed to noninvasively assess regional conduction velocities and their association with arrhythmia-free survival after PVI. METHODS A consecutive 52 patients scheduled for AF ablation (PVI only) and 19 healthy controls were prospectively included and received electrocardiographic imaging (ECGi) to noninvasively determine regional atrial conduction velocities in sinus rhythm. A novel ECGi technology obviating the need of additional computed tomography or cardiac magnetic resonance imaging was applied and validated by invasive mapping. RESULTS Mean ECGi-determined atrial conduction velocities were significantly lower in AF patients than in healthy controls (1.45 6 0.15 m/s vs 1.64 6 0.15 m/s; P < .0001). Differences were particularly pronounced in a regional analysis considering only the segment with the lowest average conduction velocity in each patient (0.8 6 0.22 m/s vs 1.08 6 0.26 m/s; P < .0001). This average conduction velocity of the ¿slowest¿ segment was independently associated with arrhythmia recurrence and better discriminated between PVI responders and nonresponders than previously proposed predictors, including left atrial size and late gadolinium enhancement (magnetic resonance imaging). Patients without slow-conduction areas (mean conduction velocity <0.78 m/s) showed significantly higher 12-month arrhythmia-free survival than those with 1 or more slow-conduction areas (88.9% vs 48.0%; P 5 .002). CONCLUSION This is the first study to investigate regional atrial conduction velocities noninvasively. The absence of ECGi-determined slow-conduction areas well discriminates PVI responders from nonresponders. Such noninvasive assessment of electrical arrhythmogenic substrate may guide treatment strategies and be a step toward personalized AF therapy., This work is supported in part by grants from the European Union s Horizon Research and Innovation Programme under the Marie Sk1odowska-Curie Grant Agreement (860974; to M.S.G.); Instituto de Salud Carlos III, Spanish Government, Madrid, Spain (FIS_PI16/00435 FIS_CIBER16; to L.M.); Ministerio de Ciencia e Innovación (supported by FEDER Fondo Europeo de Desarrollo Regional PI17/01106, PEJ2018-003617, and RYC2018-024346-I; to A.M.C.), EIT Health (SAVE-COR Activity code 220385, EIT Health is supported by EIT, a body of the European Union), Generalitat Valenciana Conselleria d Educació, Investigació, Cultura i Esport (ACIF/2020/265; to A.C.), and Spanish Agencia Estatal de Investigación (AEI), part of the Ministerio de Ciencia e Innovación, reference PID2020-119364RB-I00 (to A.C.).